Integra Lifesciences Holdings SG&A Expense (Annual) Analysis

Integra Lifesciences Holdings Corp (IART)

29.12 +0.37 (+1.29%) USD | NASDAQ | Jun 28, 16:00

29.12 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1995. Upgrade now.

Date	Value
December 31, 2023	656.64M
December 31, 2022	616.32M
December 31, 2021	637.44M
December 31, 2020	594.53M
December 31, 2019	687.60M
December 31, 2018	690.75M
December 31, 2017	624.10M
December 31, 2016	455.63M
December 31, 2015	415.76M
December 31, 2014	375.54M
December 31, 2013	332.19M
December 31, 2012	373.11M
December 31, 2011	358.13M
December 31, 2010	305.06M
December 31, 2009	281.10M

Date	Value
December 31, 2008	281.00M
December 31, 2007	225.19M
December 31, 2006	157.71M
December 31, 2005	98.27M
December 31, 2004	99.36M
December 31, 2003	59.46M
December 31, 2002	40.59M
December 31, 2001	32.37M
December 31, 2000	43.85M
December 31, 1999	22.81M
December 31, 1998	15.69M
December 31, 1997	19.90M
December 31, 1996	9.60M
December 31, 1995	6.10M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

594.53M

Minimum

2020

687.60M

Maximum

2019

638.51M

Average

637.44M

Median

2021

SG&A Expense (Annual) Benchmarks